I. Introduction: Two Conferences, One Reality This past week at DIA and BIO offered two very different views of the clinical research world. DIA felt
I. Introduction: Two Conferences, One Reality This past week at DIA and BIO offered two very different views of the clinical research world. DIA felt
In clinical research, where accuracy, coordination, and compliance are non-negotiable, the greatest threat isn’t always a lack of knowledge. Sometimes, it’s the mistaken belief that
Clinical trials professionals face a host of challenges: for some, it’s the complexity in protocol design, for many it’s lagging enrollment rates, and for others it’s the site burden that’s inherent to change management.
The compounding benefits of effective training cannot be overstated. When clinical research associates (CRAs) and site staff are thoroughly prepared, they engage more deeply with the trial protocols, ask more insightful questions, and more proactively anticipate challenges.
I was recently invited to deliver a keynote presentation on embracing change. The audience was more than a 100 healthcare improvement and clinical trial professionals who had each committed to participate in a year-long collaborative.
The formal Formal adoption of the E6(R3) guideline introduces a proportionate and more modern risk-based approach to quality management. Clinical trial leaders must implement more effective training programs that address increased trial complexity and ensure compliance with the enhanced quality requirements.
Four strategies for implementing this approach in clinical trial staff and site training. Brian S. McGowan, PhD, FACEHP, Chief Learning Officer and Co-Founder, ArcheMedX, Inc.
Ready has powered more than 1,000,000 user sessions with clinical professionals from over 90 countries to become the preferred study training tool for over 80% of site personnel.
We all like to believe trial decisions are purely rational. But behavioral science says otherwise. Trial teams rely on mental shortcuts, or heuristics, to make complex decisions faster. These shortcuts can be helpful in the moment, but they also introduce risk.
The concept of sludge provides an invaluable lens for clinical research professionals in identifying and mitigating unnecessary friction and bottlenecks.
Trial leaders recognize traditional site initiation processes often lead to excessive delays but have struggled to adapt and improve.
Learn the value of slow thinking in enhancing decision-making and outcomes in clinical research and beyond.
ArcheMedX helps life sciences and healthcare organizations to better equip, evaluate, and predict team and clinician performance
